Relay Therapeutics Inc.

NASDAQ: RLAY · Real-Time Price · USD
3.54
0.15 (4.42%)
At close: Aug 15, 2025, 3:59 PM
3.60
1.80%
After-hours: Aug 15, 2025, 07:53 PM EDT

Relay Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
124.29M 143.74M 151.79M 280.12M
Short-Term Investments
657.04M 606.35M 847.12M 677.95M
Long-Term Investments
n/a 2.71M 2.58M 2.58M
Other Long-Term Assets
2.12M n/a 2.58M 2.58M
Receivables
n/a n/a 5.22M 4.94M
Inventory
n/a n/a 12.11M -682.49M
Other Current Assets
10.53M 3.31M -8.85M 684.25M
Total Current Assets
809.2M 770.1M 1.02B 976.24M
Property-Plant & Equipment
57.67M 68.87M 75.39M 27.32M
Goodwill & Intangibles
2.3M 2.3M 2.3M 2.3M
Total Long-Term Assets
62.09M 73.88M 80.27M 32.2M
Total Assets
871.3M 843.98M 1.1B 1.01B
Account Payables
14.1M 9.21M 10.58M 8.28M
Deferred Revenue
7.68M n/a n/a 248K
Short-Term Debt
n/a n/a n/a 1.84M
Other Current Liabilities
2.1M 1.91M 47.81M -855K
Total Current Liabilities
50.73M 30.27M 63.71M 24.32M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 13.21M 32.38M 65.26M
Total Long-Term Liabilities
42.77M 61.71M 85.84M 86.31M
Total Liabilities
93.5M 91.98M 149.55M 110.64M
Total Debt
48.5M 53.47M 57.74M 22.9M
Common Stock
168K 127K 121K 109K
Retained Earnings
-1.74B -1.4B -1.06B -768.1M
Comprehensive Income
-991K -196K -10.42M -1.09M
Shareholders Equity
777.79M 752M 950.22M 897.81M
Total Investments
657.04M 606.35M 847.12M 677.95M